PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonology, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia.\', \'Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia. Electronic address: andree.kurniawan@uph.edu.\', \'Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia.\', \'Department of Radiology, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia.\', \'Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1043-4666(20)30409-910.1016/j.cyto.2020.155393
?:doi
?:hasPublicationType
?:journal
  • Cytokine
is ?:pmid of
?:pmid
?:pmid
  • 33333393
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.433
?:rankingScore_hIndex
  • 99
is ?:relation_isRelatedTo_publication of
?:title
  • Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all